Search clinical trials for: SAIZEN®

Total 19953 results

Merck KGaA, Darmstadt, Germany
Merck Ltd., Taiwan; Merck Pte. Ltd., Singapore; PT Merck Tbk., Indonesia, an...

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore) (ECOS TW ID SG)

Growth Disorders

Singapore, Taiwan, Indonesia
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Completed

Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome

Fibromyalgia

Spain
Merck KGaA, Darmstadt, Germany

Completed

Saizen® E-Device User Trial

Growth Disorders
Merck KGaA, Darmstadt, Germany
Merck Serono S.A., Geneva

Completed

Saizen in Intra-uterine Growth Retardation

Children Born With Serious Intra-uterine Growth Retardation
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S., an affiliate of Merck KGaA, Darmstadt, Germany

Completed

Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age (SGA OPTIMIS)

Small Gestational Age (SGA)
Central DuPage Hospital
Zimmer Biomet; Halifax Biomedical Inc.

Unknown

A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene

Radiostereometric Analysis | Vitamin E Liner | Zimmer® Continuum® Acetabular Cup

United States
Merck KGaA, Darmstadt, Germany

Completed

An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency

United Kingdom, Germany, Australia, Sweden
Merck KGaA, Darmstadt, Germany

Completed

Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

Turner's Syndrome

France
EMD Serono

Completed

Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency

Pituitary Dwarfism | Childhood-onset Growth Hormone Deficiency

United States
Semmes-Murphey Foundation

Unknown

Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration

Pain | Degenerative Disc Disease

United States
Merck KGaA, Darmstadt, Germany

Completed

A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood

Growth Hormone Deficiency | Dwarfism
Merck KGaA, Darmstadt, Germany

Completed

A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Idiopathic Short Stature

Korea, Republic of
EMD Serono

Terminated

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Growth Hormone Deficiency (GHD)

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

Implant Breast Reconstruction | TiLOOP® Bra Mesh | Bovine Pericardial Patch

China
Hospital de Base

Not yet recruiting

Diagnostic Accuracy Study of a Point-of-Care Test for Coagulation Function

CoaguChek® XS System | Coagulation Function
King Abdulaziz University

Completed

Effect of Carriere® Motion™ Appliance on Airway Dimensions

Effect of Carriere® Motion™ Appliance on Pharyngeal Airway Dimensions | Effect of Carriere® Motion™ Appliance on Skeletal and Dental Measurements

Saudi Arabia
Allergan

Completed

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Patients Who Participated in an Intravitreal Brimo PS DDS® Study

France, United Kingdom, Korea, Republic of, Czech Republic, Australia, Israel, India, Portugal, Germany, United States, Italy, Philippines
Johanna Maria Vermeulen
Nanjing University of Chinese Medicine; Mermaid Medicine®

Completed

Acupuncture for Nasal Congestion in Allergic Rhinitis (ANCAR)

Allergic Rhinitis

Netherlands
Pierre Fabre Dermo Cosmetique

Completed

Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

Acne

Portugal
Central Clinical Hospital of the Ministry of Internal...

Completed

First-in-man Sirolimus-eluting Prolim® Stent Registry

Sirolimus-eluting Stainless Steel Coronary Stent Prolim®
TriHealth Inc.

Completed

Long-term Usage of the Fitbit® Among Medical Residents

Continuous Fitbit® Use
B.Braun Médical - CoE Chasseneuil

Not yet recruiting

The Performance / Safety of the Celsite® Venous Access Ports (CAP)

The Performance / Safety of the Celsite® Venous Access Ports
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin) (SEPAGE)

Infant, Small for Gestational Age

France
Galderma R&D

Completed

ORCA - Oracea® for Rosacea: A Community-based Assessment

Rosacea

United States
Merck KGaA, Darmstadt, Germany

Completed

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Growth Hormone Deficiency | Turner Syndrome

Argentina, Australia, Austria, Canada, France, Germany, Italy, Norway, Russian Federation, Singapore, Spain, Sweden, United Kingdom
Duquesne University
OsteoStrong

Active, not recruiting

Melatonin and Osteogenic Loading on Osteopenia (MelaOstrong)

Osteopenia

United States
Piramal Enterprises Limited
Profil Institute for Clinical Research, Inc.

Completed

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

Healthy

United States
Göteborg University

Recruiting

Effectiveness of Meshed Free Gingival Graft for Widening of Keratinized Tissues

Gingiva Atrophy

United Arab Emirates
University of Pittsburgh
Merck Sharp & Dohme LLC; RTI International; Rite Aid Corp.; Pharmacy Quality Alliance

Completed

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications (ECO-PHIL)

Medication Adherence

United States
Hadassah Medical Organization

Completed

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

Pulpotomies Primary Teeth | Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth

Israel
A.A. Partners, LLC

Unknown

3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (3-D-TEBE)

Bone Defects

Ukraine
Pacific Centre for Reproductive Medicine
EMD Serono

Terminated

Growth Hormone in Poor Responders to IVF Trial

Infertility

Canada
Hadassah Medical Organization

Completed

Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Israel
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

Hypochondroplasia

France
Southwestern Regional Medical Center

Completed

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

Carcinoma, Non-Small-Cell Lung

United States
Clinique Ovo
EMD Serono

Completed

Adjuvant Growth Therapy in in Vitro Fertilization

Infertility

Canada
University of Chicago

Active, not recruiting

Thirty Million Words Home Visiting (TMW HV RCT)

Language Environments of Children of Low-socioeconomic Status

United States
Pró Circulação®

Completed

Training-induced Muscle Strength and Its Role in Interface Pressure in Inelastic Compression

Resistance Training

Brazil
Croma-Pharma GmbH

Completed

Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation (SayLip)

Abnormal Lip

Austria
Merck KGaA, Darmstadt, Germany
Merck A.E., Greece

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece (ECOS GRE)

Growth Disorders

Greece
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Dwarfism, Pituitary
Merck KGaA, Darmstadt, Germany
Merck S.A. Columbia

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia (ECOS COL)

Growth Disorders

Colombia
Merck KGaA, Darmstadt, Germany
Merck Gesellschaft mbH, Austria

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria (ECOS AUT)

Growth Disorders

Austria
Merck KGaA, Darmstadt, Germany
EMD Serono, a division of EMD Inc., Canada

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment (ECOS CAN)

Growth Disorders

Canada
Federico II University

Completed

Growth Hormone Deficiency in Chronic Heart Failure: A Preliminary Trial

Heart Failure | Ischemic Heart Disease | Growth Hormone Deficiency
RAND

Completed

Evaluation of the Effectiveness of a Home Visiting Program for New Parents in New Mexico

Infant Health Risk Factors

United States
AMAG Pharmaceuticals, Inc.

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Limited, UK

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK (ECOS UK)

Growth Disorders

United Kingdom
University of Chicago

Completed

TMP-Visitas al Hogar (TMP-HV RCT)

Language Development

United States
Federico II University

Completed

Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity (GH&LASGB)

Obesity | GHD

Italy

Search clinical trials for: SAIZEN®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations